[an error occurred while processing this directive] | [an error occurred while processing this directive]
Research advances in the evaluation and prevention of radiation-induced heart damage in breast cancer
Chen Siye, Wang Shulian
Department of Radiation Oncology,National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences,Peking Union Medical College,Beijing 100021,China
Abstract Radiotherapy is an essential part of postoperative adjuvant therapy for breast cancer. However, postoperative radiotherapy for breast cancer poses a potential risk of heart damage. This article summarizes the general information and diagnosis and assessment indices of radiation-induced heart damage and its risk factors, as well as the influencing factors for radiotherapy and effective protective measures.
Corresponding Authors:
Wang Shulian,Email:wangshulian@sohu.com
Cite this article:
Chen Siye,Wang Shulian. Research advances in the evaluation and prevention of radiation-induced heart damage in breast cancer[J]. Chinese Journal of Radiation Oncology, 2017, 26(4): 474-480.
Chen Siye,Wang Shulian. Research advances in the evaluation and prevention of radiation-induced heart damage in breast cancer[J]. Chinese Journal of Radiation Oncology, 2017, 26(4): 474-480.
[1] Sardaro A,Petruzzelli MF,D'Errico MP,et al. Radiation-induced cardiac damage in early left breast cancer patients:risk factors,biological mechanisms,radiobiology,and dosimetric constraints[J].Radiother Oncol,2012,103(2):133-142.DOI:10.1016/j.radonc.2012.02.008 [2] Clarke M,Collins R,Darby S,et al. Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:an overview of the randomised trials[J].Lancet,2005,366(9503):2087-2106.DOI:10.1016/S0140-6736(05)67887-7 [3] Boekel NB,Schaapveld M,Gietema JA,et al. Cardiovascular disease risk in a large,population-based cohort of breast cancer survivors[J].Int J Radiat Oncol Biol Phys,2016,94(5):1061-1072.DOI:10.1016/j.ijrobp.2015.11.040 [4] Bouillon K,Haddy N,Delaloge S,et al. Long-term cardiovascular mortality after radiotherapy for breast cancer[J].J Am Coll Cardiol,2011,57(4):445-452.DOI:10.1016/j.jacc.2010.08.638 [5] Ye JC,Yan W,Christos P,et al. Second cancer,breast cancer,and cardiac mortality in stage T1aN0 breast cancer patients with or without external beam radiation therapy:a national registry study[J].Clin Breast Cancer,2015,15(1):54-59.DOI:10.1016/j.clbc.2014.07.003 [6] Yeboa DN,Evans SB.Contemporary breast radiotherapy and cardiac toxicity[J].Semin Radiat Oncol,2016,26(1):71-78.DOI:10.1016/j.semradonc.2015.09.003 [7] Roychoudhuri R,Robinson D,Putcha V,et al. Increased cardiovascular mortality more than fifteen years after radiotherapy for breast cancer:a population-based study[J].BMC Cancer,2007,7:9.DOI:10.1186/1471-2407-7-9 [8] Abdel-Qadir H,Austin PC,Lee DS,et al. A population-based study of cardiovascular mortality following early-stage breast cancer[J].JAMA Cardiol,2016.DOI:10.1001/jamacardio.2016.3841 [9] Darby SC,Cutter DJ,Boerma M,et al. Radiation-related heart disease:current knowledge and future prospects[J].Int J Radiat Oncol Biol Phys,2010,76(3):656-665.DOI:10.1016/j.ijrobp.2009.09.064. [10] Yarnold J,Brotons MV.Pathogenetic mechanisms in radiation fibrosis[J].Radiother Oncol,2010,97(1):149-161.DOI:10.1016/j.radonc.2010.09.002. [11] Schultz-Hector S,Trott KR.Radiation-induced cardiovascular diseases:is the epidemiologic evidence compatible with the radiobiologic data?[J].Int J Radiat Oncol Biol Phys,2007,67(1):10-18.DOI:10.1016/j.ijrobp.2006.08.071. [12] 盖凯.乳腺癌放疗导致心脏损伤的相关研究进展[J].医学综述,2014,20(20):3708-3710.DOI:10.3969/j.issn.1006-2084.2014.20.024. Gai K.Advances in research on cardiac injury caused by radiotherapy of breast cancer[J].Med Rec,2014,20(20):3708-3710.DOI:10.3969/j.issn.1006-2084.2014.20.024. [13] Bovelli D,Plataniotis G,Roila F,et al. Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease:ESMO clinical practice guidelines[J].Ann Oncol,2010,21(S5):v277-v282.DOI:10.1093/annonc/mdq200. [14] Stewart FA.Mechanisms and dose-response relationships for radiation-induced cardiovascular disease[J].Ann ICRP,2012,41(3-4):72-79.DOI:10.1016/j.icrp.2012.06.031. [15] Darby SC,Ewertz M,McGale P,et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer[J].N Engl J Med,2013,368(11):987-998.DOI:10.1056/NEJMoa1209825. [16] 宁博.心肌肌钙蛋白T在放射性心肌损伤监测中的价值[J].医学综述,2011,17(5):655-658.DOI:10.3969/j.issn.1006-2084.2011.05.006. Ning B.The value of cardiac troponin T in the monitoring of myocardial injury[J].Med Rec,2011,17(5):655-658.DOI:10.3969/j.issn.1006-2084.2011.05.006. [17] Erven K,Florian A,Slagmolen P,et al. Subclinical cardiotoxicity detected by strain rate imaging up to 14 months after breast radiation therapy[J].Int J Radiat Oncol Biol Phys,2013,85(5):1172-1178.DOI:10.1016/j.ijrobp.2012.09.022. [18] Skytt? T,Tuohinen S,Boman E,et al. Troponin T-release associates with cardiac radiation doses during adjuvant left-sided breast cancer radiotherapy[J].Radiat Oncol,2015,10:141.DOI:10.1186/s13014-015-0436-2. [19] Curigliano G,Cardinale D,Dent S,et al. Cardiotoxicity of anticancer treatments:epidemiology,detection,and management[J].CA Cancer J Clin,2016,66(4):309-325.DOI:10.3322/caac.21341. [20] Zidan A,Sherief LM,El-sheikh A,et al. NT-proBNP as early marker of subclinical late cardiotoxicity after doxorubicin therapy and mediastinal irradiation in childhood cancer survivors[J].Dis Markers,2015,2015:513219.DOI:10.1155/2015/513219. [21] D'Errico MP,Petruzzelli MF,Gianicolo EAL,et al. Kinetics of B-type natriuretic peptide plasma levels in patients with left-sided breast cancer treated with radiation therapy:results after one-year follow-up[J].Int J Radiat Biol,2015,91(10):804-809.DOI:10.3109/09553002.2015.1027421. [22] . Palumbo I,Palumbo B,Fravolini ML,et al. Brain natriuretic peptide as a cardiac marker of transient radiotherapy-related damage in left-sided breast cancer patients:a prospective study[J].Breast,2016,25:45-50.DOI:10.1016/j.breast.2015.10.004. [23] Gomez DR,Yusuf SW,Munsell MF,et al. Prospective exploratory analysis of cardiac biomarkers and electrocardiogram abnormalities in patients receiving thoracic radiation therapy with high-dose heart exposure[J].J Thorac Oncol,2014,9(10):1554-1560.DOI:10.1097/JTO.0000000000000306. [24] Adar A,Canyilmaz E,Kiris A,et al. Radiotherapy induces development of fragmented QRS in patients with breast cancer[J].Breast Care (Basel),2015,10(4):277-280.DOI:10.1159/000431030. [25] 吴钦丹,陈德芳.心脏放射损伤的心电图变化观察(附120例分析)[J].福建医药杂志,2011,33(6):143-144.DOI:10.3969/j.issn.1002-2600.2011.06.080. Wu QD,Chen DF.Changes of electrocardiogram (ECG) in patients with cardiac radiation injury (analysis of 120 cases)[J].,2011,33(6):143-144.DOI:10.3969/j.issn.1002-2600.2011.06.080. [26] 杜纪昌,武霞,汪延明.SPECT心肌灌注显像评价胸部肿瘤放疗对心脏功能的影响[J].中华临床医师杂志(电子版),2012,6(14):4134-4136.DOI:10.3877/cma.j.issn.1674-0785.2012.14.079. Du JC,Wu X,Wang YM,Evaluation of cardiac function in patients with thoracic tumor by SPECT myocardial perfusion imaging [J].Chin J Clin(Elect ed),2012,6(14):4134-4136.DOI:3877/cma.j.issn.1674-0785.2012.14.079. [27] Lancellotti P,Nkomo VT,Badano LP,et al. Expert consensus for multi-modality imaging evaluation of cardiovascular complications of radiotherapy in adults:a report from the European association of cardiovascular imaging and the American society of echocardiography[J].Eur Heart J Cardiovasc Imaging,2013,14(8):721-740.DOI:10.1093/ehjci/jet123. [28] Jones RL,Swanton C,Ewer MS.Anthracycline cardiotoxicity[J].Expert Opin Drug Saf,2006,5(6):791-809.DOI:10.1517/14740338.5.6.791. [29] 蔡晓红,熊云涛,张卫林,等.超声心动图评价放射性心脏病的现状及进展[J].中国医学影像学杂志,2016,24(5):392-395.DOI:10.3969/j.issn.1005-5185.2016.05.021. Cai XH,Xiong YT,Zhang WL,et al. The status and progress of echocardiography in the evaluation of radiation heart disease[J].Chin J Med Imag,2016,24(5):392-395.DOI:10.3969/j.issn.1005-5185.2016.05.021. [30] Lo Q,Hee L,Batumalai V,et al. Subclinical cardiac dysfunction detected by strain imaging during breast irradiation with persistent changes 6 weeks after treatment[J].Int J Radiat Oncol Biol Phys,2015,92(2):268-276.DOI:10.1016/j.ijrobp.2014.11.016. [31] Erven K,Jurcut R,Weltens C,et al. Acute radiation effects on cardiac function detected by strain rate imaging in breast cancer patients[J].Int J Radiat Oncol Biol Phys,2011,79(5):1444-1451.DOI:10.1016/j.ijrobp.2010.01.004. [32] Bayram C,?tin I,Tavil B,et al. Evaluation of cardiotoxicity by tissue Doppler imaging in childhood leukemia survivors treated with low-dose anthracycline[J].Pediatr Cardiol,2015,36(4):862-866.DOI:10.1007/s00246-015-1096-6. [33] Tuohinen SS,Skytt? T,Virtanen V,et al. Detection of radiotherapy-induced myocardial changes by ultrasound tissue characterisation in patients with breast cancer[J].Int J Cardiovasc Imaging,2016,32(5):767-776.DOI:10.1007/s10554-016-0837-9. [34] Zhang P,Hu XD,Yue JB,et al. Early detection of radiation-induced heart disease using 99mTc-MIBI SPECT gated myocardial perfusion imaging in patients with oesophageal cancer during radiotherapy[J].Radiother Oncol,2015,115(2):171-178.DOI:10.1016/j.radonc.2015.04.009. [35] Marks LB,Yu XL,Prosnitz RG,et al. The incidence and functional consequences of RT-associated cardiac perfusion defects[J].Int J Radiat Oncol Biol Phys,2005,63(1):214-223.DOI:10.1016/j.ijrobp.2005.01.029. [36] Chung E,Corbett JR,Moran JM,et al. Is there a dose-response relationship for heart disease with low-dose radiation therapy?[J].Int J Radiat Oncol Biol Phys,2013,85(4):959-964.DOI:10.1016/j.ijrobp.2012.08.002. [37] Mast ME,Heijenbrok MW,van Kempen-Harteveld ML,et al. Less increase of CT-based calcium scores of the coronary arteries:effect three years after breast-conserving radiotherapy using breath-hold[J].Strahlenther Onkol,2016,192(10):696-704.DOI:10.1007/s00066-016-1026-4. [38] Nguyen KL,Hu P,Ennis DB,et al. Cardiac MRI:a translational imaging tool for characterizing anthracycline-induced myocardial remodeling[J].Curr Oncol Rep,2016,18(8):48.DOI:10.1007/s11912-016-0533-x. [39] Greenwood JP,Maredia N,Younger JF,et al. Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC):a prospective trial[J].Lancet,2012,379(9814):453-460.DOI:10.1016/S0140-6736(11)61335-4. [40] Heggemann F,Grotz H,Welzel G,et al. Cardiac function after multimodal breast cancer therapy assessed with functional magnetic resonance imaging and echocardiography imaging[J].Int J Radiat Oncol Biol Phys,2015,93(4):836-844.DOI:10.1016/j.ijrobp.2015.07.2287. [41] Jacob S,Pathak A,Franck D,et al. Early detection and prediction of cardiotoxicity after radiation therapy for breast cancer:the BACCARAT prospective cohort study[J].Radiat Oncol,2016,11:54.DOI:10.1186/s13014-016-0627-5. [42] Darby SC,McGale P,Taylor CW,et al. Long-term mortality from heart disease and lung cancer after radiotherapy for early breast cancer:prospective cohort study of about 300 000 women in US SEER cancer registries[J].Lancet Oncol,2005,6(8):557-565.DOI:10.1016/S1470-2045(05)70251-5. [43] McGale P,Darby SC,Hall P,et al. Incidence of heart disease in 35,000 women treated with radiotherapy for breast cancer in Denmark and Sweden[J].Radiother Oncol,2011,100(2):167-175.DOI:10.1016/j.radonc.2011.06.016. [44] Wollschl?ger D,Karle H,Stockinger M,et al. Radiation dose distribution in functional heart regions from tangential breast cancer radiotherapy[J].Radiother Oncol,2016,119(1):65-70.DOI:10.1016/j.radonc.2016.01.020. [45] Giordano SH,Kuo YF,Freeman JL,et al. Risk of cardiac death after adjuvant radiotherapy for breast cancer[J].J Natl Cancer Inst,2005,97(6):419-424.DOI:10.1093/jnci/dji067. [46] Rutter CE,Chagpar AB,Evans SB.Breast cancer laterality does not influence survival in a large modern cohort:implications for radiation-related cardiac mortality[J].Int J Radiat Oncol Biol Phys,2014,90(2):329-334.DOI:10.1016/j.ijrobp.2014.06.030. [47] Bouchardy C,Rapiti E,Usel M,et al. Excess of cardiovascular mortality among node-negative breast cancer patients irradiated for inner-quadrant tumors[J].Ann Oncol,2010,21(3):459-465.DOI:10.1093/annonc/mdp341. [48] Vulsteke C,Pfeil AM,Maggen C,et al. Clinical and genetic risk factors for epirubicin-induced cardiac toxicity in early breast cancer patients[J].Breast Cancer Res Treat,2015,152(1):67-76.DOI:10.1007/s10549-015-3437-9. [49] Zagar TM,Cardinale DM,Marks LB.Breast cancer therapy-associated cardiovascular disease[J].Nat Rev Clin Oncol,2016,13(3):172-184.DOI:10.1038/nrclinonc.2015.171. [50] Nathan PC,Amir E,Abdel-Qadir H.Cardiac outcomes in survivors of pediatric and adult cancers[J].Can J Cardiol,2016,32(7):871-880.DOI:10.1016/j.cjca.2016.02.065. [51] Mantarro S,Rossi M,Bonifazi M,et al. Risk of severe cardiotoxicity following treatment with trastuzumab:a meta-analysis of randomized and cohort studies of 29,000 women with breast cancer[J].Intern Emerg Med,2016,11(1):123-140.DOI:10.1007/s11739-015-1362-x. [52] Cao L,Cai G,Chang C,et al. Diastolic dysfunction occurs early in HER2-positive breast cancer patients treated concurrently with radiation therapy and trastuzumab[J].Oncologist,2015,20(6):605-614.DOI:10.1634/theoncologist.2014-0299. [53] Abdel-Qadir H,Amir E,Fischer HD,et al. The risk of myocardial infarction with aromatase inhibitors relative to tamoxifen in post-menopausal women with early stage breast cancer[J].Eur J Cancer,2016,68:11-21.DOI:10.1016/j.ejca.2016.08.022. [54] Haque R,Shi J,Schottinger JE,et al. Cardiovascular disease after aromatase inhibitor use[J].JAMA Oncol,2016,2(12):1590-1597.DOI:10.1001/jamaoncol.2016.0429. [55] Skytt? T,Tuohinen S,Virtanen V,et al. The concurrent use of aromatase inhibitors and radiotherapy induces echocardiographic changes in patients with breast cancer[J].Anticancer Res,2015,35(3):1559-1566. [56] Hooning MJ,Botma A,Aleman BMP,et al. Long-term risk of cardiovascular disease in 10-year survivors of breast cancer[J].J Natl Cancer Inst,2007,99(5):365-375.DOI:10.1093/jnci/djk064. [57] Madan R,Benson R,Sharma DN,et al. Radiation induced heart disease:pathogenesis,management and review literature[J].J Egypt Natl Canc Inst,2015,27(4):187-193.DOI:10.1016/j.jnci.2015.07.005. [58] Leung HW,Chan AL,Muo CH.Late cardiac morbidity of adjuvant radiotherapy for early breast cancer-a population-based study[J].J Cardiol,2016,67(6):567-571.DOI:10.1016/j.jjcc.2015.07.009. [59] Shah C,Badiyan S,Berry S,et al. Cardiac dose sparing and avoidance techniques in breast cancer radiotherapy[J].Radiother Oncol,2014,112(1):9-16.DOI:10.1016/j.radonc.2014.04.009. [60] Mast ME,Vredeveld EJ,Credoe HM,et al. Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients[J].Breast Cancer Res Treat,2014,148(1):33-39.DOI:10.1007/s10549-014-3149-6. [61] Formenti SC,DeWyngaert JK,Jozsef G,et al. Prone vs. supine positioning for breast cancer radiotherapy[J].JAMA,2012,308(9):861-863.DOI:10.1001/2012.jama.10759. [62] Paszat LF,Mackillop WJ,Groome PA,et al. Mortality from myocardial infarction following postlumpectomy radiotherapy for breast cancer:a population-based study in Ontario,Canada[J].Int J Radiat Oncol Biol Phys,1999,43(4):755-762.DOI:10.1016/S0360-3016(98)00412-X. [63] Chan EK,Woods R,McBride ML,et al. Adjuvant hypofractionated versus conventional whole breast radiation therapy for early-stage breast cancer:long-term hospital-related morbidity from cardiac causes[J].Int J Radiat Oncol Biol Phys,2014,88(4):786-792.DOI:10.1016/j.ijrobp.2013.11.243. [64] Appelt AL,Vogelius IR,Bentzen SM.Modern hypofractionation schedules for tangential whole breast irradiation decrease the fraction size-corrected dose to the heart[J].Clin Oncol (R Coll Radiol),2013,25(3):147-152.DOI:10.1016/j.clon.2012.07.012. [65] Korreman SS,Pedersen AN,Aarup LR,et al. Reduction of cardiac and pulmonary complication probabilities after breathing adapted radiotherapy for breast cancer[J].Int J Radiat Oncol Biol Phys,2006,65(5):1375-1380.DOI:10.1016/j.ijrobp.2006.03.046. [66] Verhoeven K,Sweldens C,Petillion S,et al. Breathing adapted radiation therapy in comparison with prone position to reduce the doses to the heart,left anterior descending coronary artery,and contralateral breast in whole breast radiation therapy[J].Pract Radiat Oncol,2014,4(2):123-129.DOI:10.1016/j.prro.2013.07.005. [67] Wiant D,Wentworth S,Liu H,et al. How important is a reproducible breath hold for deep inspiration breath hold breast radiation therapy?[J].Int J Radiat Oncol Biol Phys,2015,93(4):901-907.DOI:10.1016/j.ijrobp.2015.06.010. [68] Yeung R,Conroy L,Long K,et al. Cardiac dose reduction with deep inspiration breath hold for left-sided breast cancer radiotherapy patients with and without regional nodal irradiation[J].Radiat Oncol,2015,10:200.DOI:10.1186/s13014-015-0511-8. [69] Rochet N,Drake JI,Harrington K,et al. Deep inspiration breath-hold technique in left-sided breast cancer radiation therapy:evaluating cardiac contact distance as a predictor of cardiac exposure for patient selection[J].Pract Radiat Oncol,2015,5(3):e127-e134.DOI:10.1016/j.prro.2014.08.003. [70] Taylor CW,Br?nnum D,Darby SC,et al. Cardiac dose estimates from Danish and Swedish breast cancer radiotherapy during 1977-2001[J].Radiother Oncol,2011,100(2):176-183.DOI:10.1016/j.radonc.2011.01.020. [71] Stewart FA,Hoving S,Russell NS.Vascular damage as an underlying mechanism of cardiac and cerebral toxicity in irradiated cancer patients[J].Radiat Res,2010,174(6):865-869.DOI:10.1667/RR1862.1. [72] Correa CR,Litt HI,Hwang WT,et al. Coronary artery findings after left-sided compared with right-sided radiation treatment for early-stage breast cancer[J].J Clin Oncol,2007,25(21):3031-3037.DOI:10.1200/JCO.2006.08.6595. [73] Nilsson G,Holmberg L,Garmo H,et al. Distribution of coronary artery stenosis after radiation for breast cancer[J].J Clin Oncol,2012,30(4):380-386.DOI:10.1200/JCO.2011.34.5900. [74] Nilsson G,Nystr?m PW,Isacsson U,et al. Radiation dose distribution in coronary arteries in breast cancer radiotherapy[J].Acta Oncol,2016,55(8):959-963.DOI:10.1080/0284186X.2016.1182209. [75] Evans SB,Panigrahi B,Northrup V,et al. Analysis of coronary artery dosimetry in the 3-dimensional era:Implications for organ-at-risk segmentation and dose tolerances in left-sided tangential breast radiation[J].Pract Radiat Oncol,2013,3(2):e55-e60.DOI:10.1016/j.prro.2012.06.007. [76] Lind PA,Pagnanelli R,Marks LB,et al. Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution[J].Int J Radiat Oncol Biol Phys,2003,55(4):914-920.DOI:10.1016/S0360-3016(02)04156-1. [77] Cao L,Cai G,Chang C,et al. Early cardiac toxicity following adjuvant radiotherapy of left-sided breast cancer with or without concurrent trastuzumab[J].Oncotarget,2016,7(1):1042-1054.DOI:10.18632/oncotarget.6053. [78] Vees H,Bigler R,Bieri S,et al. Assessment of cardiac exposure in left-tangential breast irradiation[J].Cancer Radiother,2011,15(8):670-674.DOI:10.1016/j.canrad.2011.03.009. [79] Kaya MG,Ozkan M,Gunebakmaz O,et al. Protective effects of nebivolol against anthracycline-induced cardiomyopathy:a randomized control study[J].Int J Cardiol,2013,167(5):2306-2310.DOI:10.1016/j.ijcard.2012.06.023. [80] Seicean S,Seicean A,Alan N,et al. Cardioprotective effect of β-adrenoceptor blockade in patients with breast cancer undergoing chemotherapy:follow-up study of heart failure[J].Circ Heart Fail,2013,6(3):420-426.DOI:10.1161/CIRCHEARTFAILURE.112.000055. [81] Seicean S,Seicean A,Plana JC,et al. Effect of statin therapy on the risk for incident heart failure in patients with breast cancer receiving anthracycline chemotherapy:an observational clinical cohort study[J].J Am Coll Cardiol,2012,60(23):2384-2390.DOI:10.1016/j.jacc.2012.07.067. [82] 张守文,张小霞,石增成,等.卡维地洛联合曲美他嗪对接受含蒽环类药物化疗乳腺癌患者的心脏保护作用[J].中国全科医学,2016,19(7):794-798.DOI:10.3969/j.issn.1007-9572.2016.07.012. Zhang SW,Zhang XX,Shi ZC,et al. Sibutramine of trimetazidine and carvedilol combined with cardiac protective effect of anthracycline containing chemotherapy in patients with breast cancer[J].Chin Gener Pract,2016,19(7):794-798.DOI:10.3969/j.issn.1007-9572.2016.07.012.
2017, Vol. 26 
